TickerGuard
Buy Day today: Neutral (60) Mixed market breadth · no major macro event
AVIR

Atea Pharmaceuticals Inc

Healthcare · Biotechnology

5.40$ +1.9% vs. previous close Closing price · As of: Sep 21, 2026

Statements

Balance Sheet

All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.

Tick rows to compare them in a chart (up to 4)

Balance Sheet AVIR
Line item 2018 2019 2020 2021 2022 2023 2024 2025
-36.7% +3,812.6% -10.5% -13.7% -10.8% -21.9% -32.2%
-36.9% +3,841.0% -10.5% -14.4% -10.7% -21.7% -32.7%
-37.2% +3,824.6% -10.1% -15.4% -77.8% -55.0% +47.9%
-37.2% +3,824.6% -10.1% -15.4% -10.6% -21.3% -33.6%
-26.8% +17.1% -52.1% +17,700.0%
+0.9% +340.8% -80.1% -58.4% +52.2% -35.1% +54.2%
+38.4% +12,869.0% -82.0% -67.5% +75.2% -42.5% +113.9%
+266.0% +5.4% +5.3% +5.4%
+40.2% -89.1% +7,456.7% -43.7% +66.7% +4.8% +190.4%
+29.6% -9.8% -13.3% -21.0% -37.2%
-206.9%
+718.7% -0.2% +7.1% -5.7% +0.2% +1.0% -3.3%

Data as of: September 21, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?